We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




Improved Tool Concentrates Tubercle Bacilli

By LabMedica International staff writers
Posted on 07 Jun 2012
A tiny filter could have a big impact around the world in the fight against tuberculosis (TB) as it detects more cases of the bacterial infection. More...


The novel technique, which involves vacuum filtering a sputum sample treated with household bleach and other simple chemicals through a small filter, could dramatically improve TB diagnoses globally, particularly in settings where the disease is common and resources are limited.

A lung disease specialist, now at the University of Florida (UF; Gainesville, FL, USA) with colleagues at the Federal University of Espírito Santo (Vitória, Brazil), used the traditional microscope-based diagnosis method as a starting point, and devised a way to identify more cases of the Mycobacterium tuberculosis infection. The most widely used way to confirm TB infection is to use a microscope to identify and count disease-causing bacteria in sputum smeared onto a glass slide. Although the method has been in continuous use for more than a century, it can be unreliable, on average catching cases only about half of the time.

Part of the problem is that sometimes sputum samples do not contain many bacteria, making it hard to detect TB. Concentrating bacteria onto a small area could help improve detection accuracy, and although previous efforts have led to improvements, they tend to require expensive equipment or technical knowhow. In some cases, gains were offset by loss of sample or safety concerns. Therefore, the quest for a low-cost, simple, effective method led back to the trusty microscope. The scientists decided to try 13 mm polycarbonate membrane filters with 1.0 µm pores, that fit neatly onto microscope slides and that concentrated the bacteria even more.

For the 314 patients in Brazil suspected as having TB, but not yet in treatment, the team modified small-filter method by adding 95% ethanol and 1% Triton X detergent to the bleach, using filters with an 0.8 µm pore size, and prefiltering the sputum digests through 25 mm polypropylene prefilters with 30 µm pores (Millipore, Billerica, MA, USA). This method detected 89% of cases, compared with 60 % detection when samples were concentrated by the currently used method of rapid spinning, and 56% detection when sputum smears were looked at directly under the microscope. Furthermore, the small-filter method identified almost three-quarters of TB-positive cases that had been incorrectly reported as negative based on the traditional technique.

Kevin Fennelly, MD, MPH, an associate professor in the UF College of Medicine, said, "A point-of-care dipstick that can say yes or no is the Holy Grail, but we're a long way from there. ‘Microscope’ has become a dirty word in the TB diagnostics world, but almost every clinical laboratory in the world has one.” The method is being tested in western Uganda, where many people have both TB and HIV. They are comparing it again with the traditional direct-smear method and with a sophisticated DNA-based test that can also detect whether bacteria are drug resistant. The study was published in the June 2012 issue of the Journal of Clinical Microbiology.

Related Links:
University of Florida
Federal University of Espírito Santo
Millipore


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Blood-Based Protein Biomarker Solution for Alzheimer's Disease
BG-DTi2000.
Hematology Consumables
Bioblood Devices
New
Neurofilament Light Chain Assay
Lumipulse G NfL Blood
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Tracking blood test trends alongside unexplained weight loss may help identify patients at increased cancer risk and support earlier investigation (Image Credit: 123RF)

Blood Test Patterns Improve Cancer Risk Assessment in Primary Care

Unexplained weight loss is a common but nonspecific presentation in primary care that can precede several types of cancer, making referral decisions difficult. Routine blood tests may produce borderline... Read more

Molecular Diagnostics

view channel
Image: NTM are about 200 environmental bacteria found in soil and water that can cause chronic, tuberculosis-like lung infections but are distinct from the Mycobacterium tuberculosis complex (Image Credit: Adobe Stock)

Rapid CRISPR Test Identifies Nontuberculous Mycobacteria Species from Respiratory Samples

Chronic lung infections caused by nontuberculous mycobacteria (NTM) are increasingly recognized but frequently mistaken for tuberculosis, complicating diagnosis and care. These infections may affect as... Read more

Immunology

view channel
Image: Although many people harbor latent Epstein-Barr virus (EBV), growing evidence has linked the virus to MS pathobiology (Image Credit: Adobe Stock)

Blood EBV Activity Biomarkers May Predict Multiple Sclerosis Relapse Months Ahead

Predicting relapse in multiple sclerosis (MS) remains difficult, limiting opportunities for timely intervention and monitoring. Although many people harbor latent Epstein-Barr virus (EBV), growing evidence... Read more

Pathology

view channel
Image Credit: Adobe Stock

Machine Learning Cytology Tool Improves Cancer Cell Identification

Cytological screening remains central to early cancer detection, but its accuracy depends heavily on expert interpretation of stained cells. Under conventional microscopy, malignant and reactive cells... Read more

Technology

view channel
Image: ADLM recommends that emerging AI tools follow the same professional oversight, quality, validation, and monitoring standards as traditional clinical testing within CLIA’s existing framework (Image Credit: Adobe Stock)

ADLM Calls for CLIA Updates to Support Safe AI Use in Laboratory Medicine

Clinical laboratories increasingly use artificial intelligence to verify, interpret, and report results, but safeguards under the Clinical Laboratory Improvement Amendments (CLIA) were designed in 1992.... Read more

Industry

view channel
Image: The acquisition adds Convergent Genomics’ UroAmp platform and proprietary urinary tumor DNA technology to Veracyte’s portfolio (Photo courtesy of Convergent Genomics)

Veracyte Acquisition Expands Urine-Based Bladder Cancer Monitoring Capabilities

Veracyte, Inc. has acquired Convergent Genomics, expanding its urology diagnostics offerings with the company’s UroAmp platform and proprietary urinary tumor DNA (utDNA) technology. UroAmp has been clinically... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.